Sourced from:Direct from Manufacturer
Quick Summary
Reliferon 3MIU Injection
Last updated on 08 Aug 2026 | 06:04 AM (IST)
₹535
MRP: ₹735
(You Save ₹200)
1 VIAL(s)
Sourced from:Direct from Manufacturer
Reliferon 3MIU Injection
Salt Composition
INTERFERON ALFA-2BMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
27% OFF
₹535
MRP: ₹735.00
Inclusive of all taxes
27% Off
Salt Composition
INTERFERON ALFA-2BMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Intalfa 3MIU Injection
INTAS PHARMACEU...
₹ 474.00/injection
11% cheaper
Introduction
Reliferon 3MIU Injection consists of the active Interferon alfa-2b. It treats various diseases, including cancers and viral infections (chronic hepatitis B, hepatitis C). It is similar to a protein that your body naturally produces called interferon. It modifies the response of the body’s immune system to help fight infections and severe diseases. This medicine helps to suppress viral replication and reduce liver inflammation.
Talk to your doctor if you have any severe heart disease, kidney disorders, liver diseases, history of seizures, autoimmune disorders, thyroid problems, or had an organ transplant before taking Reliferon 3MIU Injection. Administration of this medicine may lead to dental and gum disorders. You should drink extra fluids to help prevent low blood pressure. Patients with a history of autoimmune disorders should be closely monitored for signs and symptoms during treatment.
Uses
Chronic myelogenous leukemia
Hairy cell leukemia
Malignant melanoma
Follicular lymphoma
Multiple myeloma
Carcinoid tumor
Viral infections such as chronic hepatitis B or C)
How Reliferon 3MIU Injection works
Reliferon 3MIU Injection works by stimulating the immune system to attack and destroy cancer cells and viruses, and it can also help manage certain symptoms associated with viral infections.
Interaction of Reliferon 3MIU Injection with other drugs
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Reliferon 3MIU Injection and reduce effectiveness by causing undesirable side effects.
Storage conditions
Store in a refrigerator between 2-8°C (56-46°F).
It should not be frozen.
Keep it in its original packaging until it is ready to be used.
Keep out of the reach of children and pets.
How to Use Reliferon 3MIU Injection
Reliferon 3MIU Injection is typically administered through injection by a healthcare provider. The specific method of administration may vary depending on the condition being treated and the healthcare provider's instructions. If a dose is missed, the patient should contact their healthcare provider for further instructions.
Safety advice
Pregnancy
Reliferon 3MIU Injection is not safe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this medicine.
Breast Feeding
It is not recommended to breastfeed while taking Reliferon 3MIU Injection because it can harm the nursing infant.
Lungs
Patients should consult their doctor if they have any pre-existing health condition before using Reliferon 3MIU Injection.
Liver
If patients have any previous liver disease then they should discuss it with their healthcare provider before using Reliferon 3MIU Injection.
Alcohol
Patients taking Reliferon 3MIU Injections avoid or limit their alcohol consumption, as alcohol can exacerbate certain side effects of the medication, such as fatigue and depression.
Driving
Patients should always monitor their response to the Reliferon 3MIU Injection medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
Side Effects
Like all medications, Reliferon 3MIU Injections cause some side effects, although not everyone will experience them.
Severe:
Severe depression
Slow growth in children and adolescents
Severe allergic reactions
Chest pain or persistent cough, shortness of breath
Mental health illness (confusion, hallucinations, changed behavior, trouble concentrating, trouble sleeping)
Severe stomach pain, black stools, blood in urine or stool
Eye problems, hearing problems
Pain, fever
High sugar levels in the blood
Common:
Headache, dizziness
Changes in appetite
Nausea, vomiting
Weight loss
Mood swings
Joint pain, muscle pain
Diarrhea, stomach pain
Thirst, dehydration
Menstrual problems
High blood pressure
Taste change, tooth ache, dry mouth
Heartburn
Constipation
SleepwalkingtoothacHeartburnhe
Increased sweating, increased need to pass urine
Bedwetting in children
Expert Tips
Read and understand all warnings and precautions before using Reliferon 3MIU Injection.
Watch for signs of allergic reactions such as rash, itching, or swelling.
Seek immediate medical help if you notice any allergic reaction symptoms.
This medicine may increase the risk of infection, so avoid close contact with people who are sick or infected.
Patients with diabetes should monitor their blood sugar levels regularly during treatment.
Avoid using this medicine during pregnancy and breastfeeding unless advised by your doctor.
Follow your doctor’s instructions carefully throughout the treatment period.
Maintain a healthy and balanced diet to support your overall health and recovery.
FAQs
Q1.
Can Reliferon 3MIU Injection be used to treat COVID-19?
While there have been some studies on the potential use of Reliferon 3MIU Injection in treating COVID-19, it is not currently approved or recommended as a standard treatment for the virus.
Q2.
Can Reliferon 3MIU Injection cause hair loss?
Hair loss is a potential side effect of Reliferon 3MIU Injection, but it is uncommon. If hair loss does occur, it is usually temporary, and the hair will regrow after treatment ends.
Q3.
Can Reliferon 3MIU Injection be used in children?
Reliferon 3MIU Injection may be used in children for certain conditions, such as hepatitis B and C, but the dosages and treatment regimens may differ from those used in adults. A healthcare provider should carefully evaluate the safety and effectiveness of children.
Q4.
Can I take Reliferon 3MIU Injection if I have a thyroid problem?
If you have a thyroid problem, such as hypothyroidism or hyperthyroidism, you should inform your healthcare provider before starting treatment with Reliferon 3MIU Injection. This medication may affect thyroid function and cause thyroid dysfunction in some patients, including hypothyroidism and hyperthyroidism.
Q5.
Can I take Reliferon 3MIU Injection if I have a heart problem?
If you have a heart problem, such as a history of heart attack, heart failure, or arrhythmia, you should inform your healthcare provider before starting treatment with Reliferon 3MIU Injection. It can cause or worsen heart problems in some patients, including chest pain, heart attack, irregular heartbeats, and heart failure.
Q6.
Can I take Reliferon 3MIU Injection if I have diabetes?
If you have diabetes, you should inform your healthcare provider before starting treatment with Reliferon 3MIU Injection. This medicine may affect blood glucose levels and cause some patients hyperglycemia or hypoglycemia. Your healthcare provider may monitor your blood glucose levels regularly during treatment and adjust your dosage or treatment plan as needed.
Fact Box
Molecule name | Interferon alfa-2b |
Therapeutic class | Antineoplastic and Immunomodulatory agent |
Pharmacological class | Interferons |
Indications | 1. Chronic myelogenous leukemia 2. Hairy cell leukemia 5. Malignant melanoma 4. Follicular lymphoma 5. Multiple myeloma 6. Carcinoid tumor 7. Viral infections such as chronic hepatitis B or C) |
References
Merck & Co., Inc., [Revised on Aug 2019] [Accessed on 5th May 2023], https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=50789790-8517-49f9-b97b-8c5ba17b55d2&type=display
R Khanna et al.; Interferon; NCBI Bookshelf; [Revised:2020] [Accessed:5 May 2023], https://www.ncbi.nlm.nih.gov/books/NBK555952/
RA Ningrum; Human Interferon Alpha-2b; A therapeutic protein for cancer treatment; [Revised on 2014] [Accessed on 5 May 2023], https://www.ncbi.nlm.nih.gov/books/NBK555952/
Merck Sharp & dome BV, Electronic medicines agency (EMA), [Revised on 2010] [Accessed on 5 May 2023], https://www.ema.europa.eu/en/documents/product-information/introna-epar-product-information_en.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 08 Aug 2026 | 06:04 AM (IST)
Want to know more?
Read Our Editorial Policy
